Miramontes Capital’s Merck MRK Stock Holding History

Miramontes Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$264K	Sell	2,051 -61	-3%	-$7.14K	0.08%	122
2026 Q1	$254K	Sell	2,112 -17	-0.8%	-$1.96K	0.09%	106
2025 Q4	$224K	Buy	+2,129	New	+$200K	0.08%	112

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Miramontes Capital's MRK Position: Q2 2026 in Review

Miramontes Capital reduced its Merck (MRK) stake by 2.9% in Q2 2026, selling an estimated $7.14K and leaving 2,051 shares worth $264K. The position accounts for 0.08% of the portfolio, ranked #122.

Miramontes Capital first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. 3,850 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Miramontes Capital held 2,051 shares of Merck worth $264K as of Q2 2026.
Miramontes Capital sold 61 Merck shares in Q2 2026, an estimated $7.14K.
Merck made up 0.08% of Miramontes Capital's portfolio in Q2 2026, its #122 holding.
Miramontes Capital first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
3,850 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Miramontes Capital's 13F filing for Q2 2026, filed 9 Sep 2026.